Rat livers perfused at constant flow via the portal vein with dibutyryl cyclic AMP produced glucose equivalents at a steady maximal rate (6 umol/min per g of liver). Addition of adenosine (150/,M) caused a biphasic effect. (i) First, the glycogenolytic rate rose transiently, to a mean peak of 150 % of control levels after 2 min. This glycogenolytic burst was reproduced by two P1-receptor agonists, but not by ATP, and was blocked by a P1-antagonist (8-phenyltheophylline), as well as by inhibitors of eicosanoid synthesis (indomethacin, ibuprofen or aspirin). It did not occur in phosphorylasekinase-deficient livers. The adenosine-induced glycogenolytic burst coincided with moderate and transient changes in portal pressure (+ 6 cmH2O) and 02 consumption (-20 %), but it could not be explained by an increase in cytosolic Pi, since the n.m.r. signal fell precipitously. (ii) Subsequently, the rate of glycogenolysis decreased to one-third of the preadenosine value, in spite of persistent maximal activation of phosphorylase. The decrease could be linked to the decline in cytosolic Pi: both changes were prevented by the adenosine kinase inhibitor 5-iodotubercidin, whereas they were not affected by ibuprofen or 8-phenyltheophylline, and were not reproduced by non-metabolized adenosine analogues. In comparison with adenosine, ATP caused a slower decrease of Pi and of glycogenolysis. The fate of the cytosolic P1 was unclear, especially with administered ATP, which did not increase the n.m.r.-detectable intracellular ATP.
INTRODUCTION
Hepatic glycogen degradation is catalysed by the phosphorylated a-form of glycogen phosphorylase. Phosphorylation is brought about by cyclic-AMP-dependent activation of phosphorylase kinase, or by a direct stimulation of the latter enzyme by increased cytosolic [Ca2+] . Phosphorylase a activity is also non-covalently regulated, e.g. by the availability of the substrate P1 [1] .
Since the discovery of ATP as a neurotransmitter, purinergic receptors have been identified in many tissues [2] . With respect to the activation of phosphorylase in hepatocytes, two purinergic mechanisms have been characterized. ATP interacts with P2Y-receptors, and evokes a transient Ca2+ response through a GTPdependent InsPJ-mediated mechanism [3, 4] . In the intact organ, ATP also stimulates thromboxane and prostaglandin release by the Kupffer cells [5, 6] , which may be involved in mediating the glycogenolytic response [5, [7] [8] [9] [10] [11] [12] . Adenosine interacts with P1-receptors that activate adenylate cyclase [13] [14] [15] . However, its glycogenolytic response is also attenuated by cyclo-oxygenase inhibitors [16] , and this is correlated with a decreased release of prostaglandin D2 [17] . Furthermore, portal administration of the purinergic mediators results in transient vasoconstriction [7, 15, 16] , which may stimulate glycogenolysis by causing regional hypoxia [18] , possibly through elevation of the cytosolic P1
concentration.
Nucleosides and nucleotides are subject to extensive hepatic metabolism. Extracellular ATP is extremely short-lived, owing to hydrolysis by ecto-pyrophosphatases and phosphatases [19, 20] , and generation of adenosine may recruit secondary P, effects.
Adenosine in turn is subject to extensive hepatic metabolism.
Adenosine administration results in accumulation of extra ATP [21] [22] [23] and a drop in cellular P1 [23, 24] . In contrast with some non-metabolized analogues, adenosine decreases the glycogenolytic effects of glucagon and catecholamines [22, 25] , and it has been suggested [25] that this might be due to P1 trapping in the synthesis of ATP. Adenosine-induced changes in ATP/ADP ratios and in cytosolic P1 have been observed, and their potential consequences for metabolic regulation have been discussed [24] .
The interaction in the intact organ ofthe mechanisms described above is poorly understood. To single out effects of adenosine that are unrelated to a covalent modification of phosphorylase, we adopted the following experimental protocol [1] . Phosphorylase was clamped in its a-form by continuous perfusion of the liver with dibutyryl cyclic AMP. From this vantage point, we looked at time-dependent effects of the administration of adenosine and non-metabolized analogues thereof. The appearance of glucose and lactate in the perfusate was monitored to assess the rate ofglycogenolysis. We used 31P-n.m.r. to investigate whether changes in the catalytic efficiency of phosphorylase could be linked to changes in cytosolic Pi. Furthermore, 31p_ n.m.r. allowed us to monitor the cytosolic pH.
MATERIALS AND METHODS

Materials
Adenosine and indonwthacin were purchased from Aldrich. ATP, 2-chloroadenosine, Arg--vasopressin (grade V), phenylephrine, propranolol and ibuprofen were from Sigma, 5'-(NEthyl)carboxamidoadenosine (NECA) was from Boehringer Mannheim, and 5-iodotubercidin was from Research Biochemicals Inc. (Natick, MA, U.S.A.). Acetylsalicylic acid was of standard pharmaceutical grade.
During the first 0.5 h of the experiment, the organ was perfused under constant pressure (flow approx. 5 ml/min per g) in recirculating mode with the perfusate supplemented with 15 mMglucose, 2.7 mM-lactate, 0.3 mM-pyruvate and 40 /sM-glycerol.
During the subsequent experimental phase, the liver was perfused at a constant flow rate of 50 ml/min in single-pass mode with nutrient-free buffer containing 100 ,tM-dibutyryl cyclic AMP. Changes in transhepatic hydrostatic pressure were read from an open-loop manometer inserted in the inflow tubing. 02 extraction was monitored with a Clark electrode inserted in the caval outflow path. Hepatic production of hexose equivalents waŝ stimated from the appearance of glucose [26] , lactate [27] and pyruvate [28] in the perfusate. At the end of the experiments (usually about 15 min after administration of test compounds) the livers were freeze-clamped for the determination of the degree of activation of glycogen phosphorylase [29] , and of residual glyccgen on alkaline extracts [30] . 31P-n.m.r. spectroscopy Spectra were obtained in a 4.7 T, 30 cm-wide bore magnet, equipped with a Biospec spectrometer (Bruker, Spectrospin). 31P-n.m.r. spectra were acquired at 81.1 MHz. Per spectrum (1.5 min), we accumulated 128 scans, using 60,s (720) pulses with a 0.69 s repetition time. The latter conditions essentially saturate Pi from extracellular origin [1, 31] .
The FIDs (free induction decays) consisted of 2048 data points; the spectral width was 5200 Hz. The accumulated FIDs were processed by convolution difference [32] to remove the broad humi typical of liver spectra. The FIDs were multiplied by a damped exponential, corresponding to 700 Hz line broadening, and the result was subtracted from the original FID. Then, in order to improve the spectral resolution, Lorentz-Gauss filtering was applied to the FIDs [33] . The FID was multiplied by a positive exponential corresponding to a line narrowing of 50-70 Hz, and then by a Gaussian function corresponding to a line broadening of 30-50 Hz.
Relative changes in Pi and ATP levels were estimated from changes in the height of the spectral peaks of P1 and of the fphosphate of nucleoside triphosphates (NTPs) respectively. Peak linewidths remained unchanged throughout the experiments. The intracellular pH was calculated from the spectral shift between the Pi and NTP a-phosphate signals, using reported chemical shift reference values and dissociation constants [34] . 
RESULTS AND DISCUSSION Biphasic modulation of maximal glycogenolysis by adenosine
Basic characteristics of the perfusion system. Continuous exposure of the liver to 100 ,tM-dibutyryl cyclic AMP causes full activation of phosphorylase within 10 min [1] . The (Fig. 1) . Lower concentrations of adenosine (20-80 /,M) had little or no effect ( Table 1) . The glycogenolytic burst seemed to be superimposed on a slower, but progressive, inhibition of glycogenolysis, which was observed with both adenosine and ATP (Fig. 1) . The inhibition occurred notwithstanding conservation of phosphorylase a levels. The drop in glycogenolytic efficacy may be related to a drop in cytosolic P1 (Fig. 1) (Fig. 2) . In keeping with P1- Fig. 1 ; 'absent' means that no peak or dip occurred. The caption 'phase 2' refers to the mean activity measured between 10 and 15 min after administration of the test substances. Changes in portal pressure are expressed as absolute increments with respect to the basal portal pressure during the control period. Lactate production is expressed as a fraction of hexose equivalents released from the liver. Fractional lactate production under control conditions was 5.9 + 0.2 % (n = 38). According to the number of experiments reported, ranges of individual values (n < 2) or means + S.E.M. (n > 2) are given. receptor involvement, the adenosine analogues 2-chloroadenosine and NECA elicited a pronounced glycogenolytic burst ( Fig. 3 and Table 1 ), but ATP at comparable concentrations remained ineffective (Fig. 1) . Hepatocellular P.-receptors are believed to exert their effect through cyclic-AMP-dependent activation of phosphorylase [13] [14] [15] . However, the continuous exposure of the liver to dibutyryl cyclic AMP would seem to pre-empt any mechanism depending on the stimulation of cyclic-AMP-dependent protein kinase. A Ca2'-mediated mechanism at the hepatocellular level seems to be excluded also, since neither vasopressin nor an aagonist modulated the maximal glycogenolysis (Table 1) .
Eicosanoid involvement. In the intact organ, adenosine may activate glycogenolysis in part through eicosanoids, generated by non-parenchymal cells [16, 17] . Perfusion with any one of the cyclo-oxygenase inhibitors ibuprofen, indomethacin or acetylsalicylic acid prevented the glycogenolytic burst ( Fig. 2 and Table 1 ). Therefore, transient stimulation of maximal glycogenolysis by adenosine is apparently eicosanoid-mediated.
Dependence on phosphorylase a. Whereas the glycogenolytic burst is not due to additional conversion of phosphorylase b into a (see above), it required the presence of active phosphorylase a.
Indeed, as shown in Table 1 [16] . The proposed scenario can explain why adenosine-induced hepatic glycogenolysis is substantially suppressed by cyclo-oxygenase inhibitors [17] .
A role for hypoxia? Portal vasoconstriction can result in redistribution of the intrahepatic microcirculation [35, 36] , and in turn in regional hypoxia and in stimulation of glycogenolysis. A likely link between hypoxia and stimulation of glycogenolysis would be an increase in cytosolic Pi [1] .
The adenosine-induced glycogenolytic burst indeed coincided with a transient vasoconstriction and diminished 02consumption ( Fig. 1 and Table 1 ). Loss of the vasoconstrictive response, be it by lowering the adenosine concentration, by Pi-receptor blockade or by cyclo-oxygenase inhibition, was correlated with loss of the glycogenolytic response. Preferential release of lactate reflected faithfully the vasoconstrictive response of adenosine (Fig. 1) . The increase in lactate coincided with a sharp and persistent drop in pyruvate, which became quasi-undetectable (results not shown). A persistently increased lactate/pyruvate ratio might be secondary to the Pi-dependence of respiration [37] .
Whereas the observations described above point to the possibility that a transient hypoxic spell could mediate the adenosineinduced glycogenolytic burst, other data do not support this hypothesis. The increase in the proportion of hexose equivalents released as lactate after adenosine administration was not specifically linked to vasoconstriction, as this increase was also observed after abolition of the latter by treatment with cyclooxygenase inhibitors (Table 1) . Furthermore, ATP did not stimulate glycogenolysis, although it provoked a more pronounced and sustained vasoconstriction and decrease in 02 consumption than did adenosine. Finally, our n.m.r. spectra revealed an immediate and precipitous decline in P1 after adenosine administration. No signs of peak-broadening or of the appearance of a hypoxic acidifying compartment were observed. The cytosolic pH before adenosine administration was 7.32 + 0.02 (n = 18), and it did not alter significantly afterwards.
It is unlikely that the stimulation of glycogenolysis by adenosine was due to accumulation of AMP, be it as a result of hypoxia or of phosphorylation of adenosine. AMP is expected to have only a very moderate effect on the catalytic efficiency of phosphorylase a [38] . Secondly, stimulation of glycogenolysis was also observed in the presence of the adenosine kinase inhibitor 5-iodotubercidin and with non-metabolized adenosine analogues (Figs. 2 and 3 and Table 1 ).
Phase 2: progressive inhibition of glycogenolysis
The gradual drop in P; explains the inhibition of glycogenolysis. After the phase 1 effect had dissipated, inhibition of glycogenolysis became apparent. The extent and rate ofinhibition differed depending on whether it was induced by adenosine or ATP, and was correlated with the evolution of cytosolic P1 (Fig.  1) . The adenosine-induced inhibition of glycogenolysis was dosedependent, but required lower concentrations of adenosine than did the glycogenolytic burst ( Table 1 ). The decrease in Pi suffices to explain the inhibition of glycogenolysis, in view of the known Pi-dependence of the catalytic efficiency of phosphorylase a [1] .
The decline in Pi and the proportional inhibition of maximal glycogenolysis can explain the observed negative co-operativity between the glycogenolytic effects of adenosine or ATP, and of other glycogenolytic agents [22, 25] . A persistent drop in P1 might also contribute to homologous desensitization to adenosine and ATP [15, 16] .
Dependence on adenosine metabolism. The progressive inhibition of glycogenolysis is not receptor-mediated, but is of metabolic origin. The phenomenon is observed with both adenosine and ATP, and is not affected by 8-phenyltheophylline or cyclo-oxygenase inhibitors, which obliterate the adenosineinduced glycogenolytic burst ( Fig. 2 and Table 1 ). One can postulate that adenosine might exert metabolic effects secondary to the accumulation of phosphorylated nucleotides [39] and/or trapping of cytosolic P1 [24] .
Conversion of adenosine to ATP, and concurrent trapping of Pi, can be prevented by blockade of adenosine phosphorylation or precluded by the use of non-metabolized adenosine analogues.
When adenosine was tested in livers treated with 10 ,M-5-iodotubercidin, an adenosine kinase inhibitor [40] , the changes in ATP and in cytosolic P1 were absent, and accordingly the drop in glycogenolysis was not observed (Fig. 2) . However, the early transient glycogenolytic burst was preserved, in keeping with its postulated P1-receptor-mediated origin. The kinase inhibitor, itself an adenosine analogue, was devoid of obvious direct P1-type effects at the tested concentration. The same results were obtained with non-metabolized adenosine analogues (Fig. 3) . It has been shown that 2-chloroadenosine (100 /SM) increases progressively the NTP pool in isolated hepatocytes over a 1 h period, apparently by conversion to 2-chloro-ATP [41] . However, we could not detect such an effect within the time scale of our experiments (Fig. 3) .
Thus the adenosine-induced changes in cytosolic Pi depend on metabolism of adenosine, via a pathway involving phosphorylation of the nucleoside. N.m.r. data showed that the adenosinetreated livers steadily accumulated ATP during the 15 min perfusion with adenosine ( Fig. 1) . However, a number of observations were inconsistent with the hypothesis that trapping in the form of ATP accounts completely for the drop in Pi.
Indeed the adenosine-induced drop in P1 occurred more swiftly than the steady increase in ATP (Fig. la) . The dissociation between reciprocal changes in P, and ATP was particularly obvious with ATP, which induced a drop in P1 without any observable growth of the ATP signal (Fig. lb) .
Trapping of P, in an intracellular compartment. To investigate the fate of cytosolic P1, livers were perfused with adenosine in a P1-free perfusion system; this allowed us to monitor P1 leakage from the liver into the perfusate (Fig. 4) . As previously observed observable cytosolic Pi. The latter was correlated with an overall decrease in Pi release into the perfusate, as expected for the concentration-gradient-driven transmembrane movement of Pi [42] .
A small transient shoulder in the P1 leakage curve at the onset of adenosine administration might reflect a transient increase in cytosolic Pi, e.g. secondary to local hypoxia. However, being far from proportional with the transient glycogenolytic burst, it falls short of explaining the latter.
The overall drop in cytosolic P1 did not stem from active Pi extrusion. Rather, P1 leakage passively followed cytosolic changes. After cessation of adenosine infusion, cytosolic P1 partially recoyered. This P1 could not come from the Pi-free extracellular compartment, or from degradation of ATP, since the accumulation of ATP continued after withdrawal of extracellular adenosine, while the cytosolic P1 increased. Apparently, adenosine challenge or withdrawal triggers movement of Pi into or out of an intracellular, possibly metabolic, but n.m.r.-unobservable compartment. The existence of such a compartment has been postulated previously [1, 43] .
Conclusions
Induction of glycogenolysis by adenosine entails more than the conversion of phosphorylase b into phosphorylase a. Our results point to the operation of mechanisms for non-covalent control of phosphorylase a activity. Adenosine enhances transiently the catalytic efficiency of phosphorylase a, possibly through eicosanoid-mediated modulation of the concentration of a hitherto unrecognized stimulator or inhibitor. Subsequently, the activity of the enzyme drops, as a result of a decline in cytosolic Pi.
